Newbridge Pharma Ltd.
Wholesale of pharmaceutical goods
Newbridge Pharma Ltd. contacts: address, phone, fax, email, website, shedule
Address: Unit 2 Brannam Crescent Roundswell Business Park EX31 3TD Barnstaple
Phone: +44-1553 6777435
Fax: +44-1553 6777435
Email: n\a
Website: n\a
Shedule:
Incorrect data or we want add more details informations for "Newbridge Pharma Ltd."? - send email to us!
Registration data Newbridge Pharma Ltd.
Register date: 2006-11-28
Register number: 06011430
Type of company: Private Limited Company
Get full report form global database UK for Newbridge Pharma Ltd.Owner, director, manager of Newbridge Pharma Ltd.
Andrew John Collier Director. Address: 31 Rumsam Gardens, Barnstaple, North Devon, EX32 9EY. DoB: December 1960, British
Lynne Collier Director. Address: 31 Rumsam Gardens, Barnstaple, Devon, EX32 9EY. DoB: July 1961, British
Jobs in Newbridge Pharma Ltd. vacancies. Career and practice on Newbridge Pharma Ltd.. Working and traineeship
Plumber. From GBP 1900
Administrator. From GBP 2200
Responds for Newbridge Pharma Ltd. on FaceBook
Read more comments for Newbridge Pharma Ltd.. Leave a respond Newbridge Pharma Ltd. in social networks. Newbridge Pharma Ltd. on Facebook and Google+, LinkedIn, MySpaceAddress Newbridge Pharma Ltd. on google map
Other similar UK companies as Newbridge Pharma Ltd.: M Lafferty Limited | Nirmal Constructions Ltd | Applefields Project Services Limited | Design Forum Building Solutions Limited | James Harkin(electrical Engineers)limited
Newbridge Pharma Ltd. has existed on the market for at least 10 years. Started with registration number 06011430 in 2006-11-28, the firm is located at Unit 2 Brannam Crescent, Barnstaple EX31 3TD. This business is classified under the NACe and SiC code 46460 and has the NACE code: Wholesale of pharmaceutical goods. October 31, 2015 is the last time account status updates were reported. This business can look back on successful ten years in this field of business, with a bright future in the future.
The firm owes its well established position on the market and unending development to exactly two directors, namely Andrew John Collier and Lynne Collier, who have been managing it since 2006-11-28.